Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1997 1
1998 1
1999 1
2001 6
2002 1
2003 7
2004 5
2005 10
2006 7
2007 4
2008 4
2009 3
2010 4
2011 10
2012 5
2013 10
2014 3
2015 2
2016 4
2017 3
2018 2
2019 2
2020 1
2021 2
Text availability
Article attribute
Article type
Publication date

Search Results

89 results
Results by year
Filters applied: . Clear all
Page 1
T-helper-1-cell cytokines drive cancer into senescence.
Braumüller H, Wieder T, Brenner E, Aßmann S, Hahn M, Alkhaled M, Schilbach K, Essmann F, Kneilling M, Griessinger C, Ranta F, Ullrich S, Mocikat R, Braungart K, Mehra T, Fehrenbacher B, Berdel J, Niessner H, Meier F, van den Broek M, Häring HU, Handgretinger R, Quintanilla-Martinez L, Fend F, Pesic M, Bauer J, Zender L, Schaller M, Schulze-Osthoff K, Röcken M. Braumüller H, et al. Nature. 2013 Feb 21;494(7437):361-5. doi: 10.1038/nature11824. Epub 2013 Feb 3. Nature. 2013. PMID: 23376950 Free article.
However, efficient inhibition of exponential cancer growth by T cells and interferon-gamma (IFN-gamma) requires additional undefined mechanisms that arrest cancer cell proliferation. Here we show that the combined action of the T-helper-1-cell cytokines IFN-gamma an …
However, efficient inhibition of exponential cancer growth by T cells and interferon-gamma (IFN-gamma) requires additional undefined …
Cancer immune control needs senescence induction by interferon-dependent cell cycle regulator pathways in tumours.
Brenner E, Schörg BF, Ahmetlić F, Wieder T, Hilke FJ, Simon N, Schroeder C, Demidov G, Riedel T, Fehrenbacher B, Schaller M, Forschner A, Eigentler T, Niessner H, Sinnberg T, Böhm KS, Hömberg N, Braumüller H, Dauch D, Zwirner S, Zender L, Sonanini D, Geishauser A, Bauer J, Eichner M, Jarick KJ, Beilhack A, Biskup S, Döcker D, Schadendorf D, Quintanilla-Martinez L, Pichler BJ, Kneilling M, Mocikat R, Röcken M. Brenner E, et al. Nat Commun. 2020 Mar 12;11(1):1335. doi: 10.1038/s41467-020-14987-6. Nat Commun. 2020. PMID: 32165639 Free PMC article.
Cytokine-induced senescence (CIS) can stably arrest cancer cells, suggesting that interferon-dependent induction of senescence-inducing cell cycle regulators is needed to control those cancer cells that escape from killing. Here we report in two different cancers sensitive to …
Cytokine-induced senescence (CIS) can stably arrest cancer cells, suggesting that interferon-dependent induction of senescence-inducing cell …
Melanocytic nevi.
Hauschild A, Egberts F, Garbe C, Bauer J, Grabbe S, Hamm H, Kerl H, Reusch M, Rompel R, Schlaeger M; expert group "Melanocytic nevi". Hauschild A, et al. J Dtsch Dermatol Ges. 2011 Sep;9(9):723-34. doi: 10.1111/j.1610-0387.2011.07741.x. Epub 2011 Jul 15. J Dtsch Dermatol Ges. 2011. PMID: 21762380 English, German. No abstract available.
UVA-Irradiation Induces Melanoma Invasion via the Enhanced Warburg Effect.
Kamenisch Y, Baban TSA, Schuller W, von Thaler AK, Sinnberg T, Metzler G, Bauer J, Schittek B, Garbe C, Rocken M, Berneburg M. Kamenisch Y, et al. J Invest Dermatol. 2016 Sep;136(9):1866-1875. doi: 10.1016/j.jid.2016.02.815. Epub 2016 May 13. J Invest Dermatol. 2016. PMID: 27185340 Free article. Review.
Oncogenetics of melanoma: basis for molecular diagnostics and therapy.
Held L, Eigentler TK, Meier F, Held M, Röcken M, Garbe C, Bauer J. Held L, et al. J Dtsch Dermatol Ges. 2011 Jul;9(7):510-6. doi: 10.1111/j.1610-0387.2011.07603.x. Epub 2011 Jan 19. J Dtsch Dermatol Ges. 2011. PMID: 21244632 Review. English, German.
Histopathological diagnostics of malignant melanoma in accordance with the recent AJCC classification 2009: Review of the literature and recommendations for general practice.
Garbe C, Eigentler TK, Bauer J, Blödorn-Schlicht N, Fend F, Hantschke M, Kurschat P, Kutzner H, Metze D, Pressler H, Reusch M, Röcken M, Stadler R, Tronnier M, Yazdi A, Metzler G. Garbe C, et al. J Dtsch Dermatol Ges. 2011 Sep;9(9):690-9. doi: 10.1111/j.1610-0387.2011.07714.x. Epub 2011 Jun 9. J Dtsch Dermatol Ges. 2011. PMID: 21651721 English, German.
Genetic and morphologic features for melanoma classification.
Broekaert SM, Roy R, Okamoto I, van den Oord J, Bauer J, Garbe C, Barnhill RL, Busam KJ, Cochran AJ, Cook MG, Elder DE, McCarthy SW, Mihm MC, Schadendorf D, Scolyer RA, Spatz A, Bastian BC. Broekaert SM, et al. Pigment Cell Melanoma Res. 2010 Dec;23(6):763-70. doi: 10.1111/j.1755-148X.2010.00778.x. Pigment Cell Melanoma Res. 2010. PMID: 20874733 Free PMC article.
We confirmed that melanomas with BRAF mutations showed characteristic morphologic features (P < 0.0001) and metastasized more frequently to regional lymph nodes (P = 0.046). ...

We confirmed that melanomas with BRAF mutations showed characteristic morphologic features (P < 0.0001) and metastasized more freq

Variables that influence BRAF mutation probability: A next-generation sequencing, non-interventional investigation of BRAFV600 mutation status in melanoma.
Gaiser MR, Skorokhod A, Gransheier D, Weide B, Koch W, Schif B, Enk A, Garbe C, Bauer J. Gaiser MR, et al. PLoS One. 2017 Nov 27;12(11):e0188602. doi: 10.1371/journal.pone.0188602. eCollection 2017. PLoS One. 2017. PMID: 29176861 Free PMC article.
The decreasing influence of increasing age on mutation probability was quantified. A main effects MLR model identified age (p = 0.0001), center (p = 0.0004), and melanoma subtype (p = 0.014) as significantly influencing BRAFV600 mutation probability; ultravio …
The decreasing influence of increasing age on mutation probability was quantified. A main effects MLR model identified age (p = 0.000 …
Preexisting and Post-COVID-19 Immune Responses to SARS-CoV-2 in Patients with Cancer.
Bilich T, Roerden M, Maringer Y, Nelde A, Heitmann JS, Dubbelaar ML, Peter A, Hörber S, Bauer J, Rieth J, Wacker M, Berner F, Flatz L, Held S, Brossart P, Märklin M, Wagner P, Erne E, Klein R, Rammensee HG, Salih HR, Walz JS. Bilich T, et al. Cancer Discov. 2021 Aug;11(8):1982-1995. doi: 10.1158/2159-8290.CD-21-0191. Epub 2021 May 19. Cancer Discov. 2021. PMID: 34011563
Unexposed patients with hematologic malignancies presented with reduced prevalence of preexisting SARS-CoV-2 cross-reactive CD4(+) T-cell responses and signs of T-cell exhaustion compared with patients with solid tumors and healthy volunteers. ...SIGNIFICANCE: This …
Unexposed patients with hematologic malignancies presented with reduced prevalence of preexisting SARS-CoV-2 cross-reactive CD4(+) T- …
89 results